Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Acadia Healthcare Company Inc’s stock clocked out at $24.29, up 0.12% from its previous closing price of $24.26. In other words, the price has increased by $0.12 from its previous closing price. On the day, 1.36 million shares were traded. ACHC stock price reached its highest trading level at $24.87 during the session, while it also had its lowest trading level at $24.23.
Ratios:
To gain a deeper understanding of ACHC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On August 14, 2025, Raymond James Downgraded its rating to Outperform which previously was Strong Buy but kept the price unchanged to $26.
Barclays Downgraded its Overweight to Equal Weight on February 28, 2025, whereas the target price for the stock was revised from $43 to $35.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 2243098880 and an Enterprise Value of 4666383872. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.00, and their Forward P/E ratio for the next fiscal year is 9.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 0.71. Its current Enterprise Value per Revenue stands at 1.445 whereas that against EBITDA is 7.238.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.98, which has changed by -0.57356036 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $60.52, while it has fallen to a 52-week low of $17.12. The 50-Day Moving Average of the stock is 7.23%, while the 200-Day Moving Average is calculated to be -13.35%.
Shares Statistics:
It appears that ACHC traded 2.72M shares on average per day over the past three months and 2394590 shares per day over the past ten days. A total of 92.35M shares are outstanding, with a floating share count of 90.67M. Insiders hold about 1.81% of the company’s shares, while institutions hold 120.55% stake in the company. Shares short for ACHC as of 1759190400 were 14164311 with a Short Ratio of 5.21, compared to 1756425600 on 11836661. Therefore, it implies a Short% of Shares Outstanding of 14164311 and a Short% of Float of 17.819999.
Earnings Estimates
. The current assessment of Acadia Healthcare Company Inc (ACHC) involves the perspectives of 13.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.61, with high estimates of $0.79 and low estimates of $0.51.
Analysts are recommending an EPS of between $2.58 and $2.33 for the fiscal current year, implying an average EPS of $2.5. EPS for the following year is $2.69, with 13.0 analysts recommending between $2.97 and $2.27.
Revenue Estimates
In. The current quarter, 12 analysts expect revenue to total $848.64M. It ranges from a high estimate of $878.2M to a low estimate of $816.76M. As of. The current estimate, Acadia Healthcare Company Inc’s year-ago sales were $815.63MFor the next quarter, 12 analysts are estimating revenue of $830.9M. There is a high estimate of $865.67M for the next quarter, whereas the lowest estimate is $813M.
A total of 12 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.34B, while the lowest revenue estimate was $3.3B, resulting in an average revenue estimate of $3.32B. In the same quarter a year ago, actual revenue was $3.15BBased on 12 analysts’ estimates, the company’s revenue will be $3.55B in the next fiscal year. The high estimate is $3.64B and the low estimate is $3.46B.
